Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation (Q43952443)

28 November 2017

title

Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation (English)

1 reference

28 November 2017

0 references

Günter Breithardt

1 reference

28 November 2017

Lars Eckardt

1 reference

28 November 2017

Gerrit Frommeyer

1 reference

28 November 2017

Peter Milberg

1 reference

28 November 2017

Timo Uphaus

series ordinal

1 reference

28 November 2017

Dennis Kaiser

series ordinal

1 reference

28 November 2017

Sven Kaese

series ordinal

1 reference

28 November 2017

publication date

1 December 2013

1 reference

Cardiovascular Therapeutics

28 November 2017

published in

1 reference

28 November 2017

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

e63-71

1 reference

Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Electrophysiologic basis for the antiarrhythmic actions of ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase‐III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing‐induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Verapamil prevents stretch-induced shortening of atrial effective refractory period in langendorff-perfused rabbit heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Synergistic action of atrial dilation and sodium channel blockade on conduction in rabbit atria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: I. Experimental analysis of the use-dependent block

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Dronedarone in High-Risk Permanent Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Increased mortality after dronedarone therapy for severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Frequency-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Mechano-electric feedback and atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

Activation of a nonselective cation channel by swelling in atrial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

A mechanosensitive K+ channel in heart cells. Activation by arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12035

21 January 2018

Identifiers

DOI

10.1111/1755-5922.12035

1 reference

28 November 2017

1 reference